cyclosporine has been researched along with Bronchiolitis, Exudative in 72 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 22 (30.56) | 18.2507 |
| 2000's | 34 (47.22) | 29.6817 |
| 2010's | 15 (20.83) | 24.3611 |
| 2020's | 1 (1.39) | 2.80 |
| Authors | Studies |
|---|---|
| Behr, J; Boerner, G; Denk, O; Ghiani, A; Jaksch, P; Kessler, R; Kneidinger, N; Knoop, C; Monforte, V; Müller-Quernheim, J; Neurohr, C; Parmar, J; Prante Fernandes, S; Sole, A; Ussetti, P; Wirtz, H | 1 |
| Bellon, H; Heigl, T; Hoet, P; Lammertyn, E; Vanaudenaerde, BM; Vandermeulen, E; Vanhove, T; Verleden, GM; Verleden, SE; Verlinden, L; Verstuyf, M; Vos, R; Vriens, H | 1 |
| Akiba, M; Eba, S; Hoshi, F; Matsuda, Y; Niikawa, H; Noda, M; Oishi, H; Okada, Y; Sado, T; Sakurada, A; Watanabe, T | 1 |
| Ahern, J; Hodge, G; Hodge, S; Holmes, M; Holmes-Liew, CL; Reynolds, PN | 1 |
| Gerull, S; Halter, JP; Hostettler, KE; Lardinois, D; Roth, M; Savic, S; Tamm, M | 1 |
| Gluud, C; Iversen, M; Møller, CH; Penninga, EI; Penninga, L; Steinbrüchel, DA | 1 |
| Aurora, P; Brozek, J; Corris, PA; Glanville, AR; Meyer, KC; Raghu, G; Verleden, GM; Wilson, KC | 1 |
| Hanakawa, Y; Hashimoto, T; Ishii, N; Matsumoto, T; Murakami, M; Namba, C; Sayama, K; Shirakata, Y; Suemori, K; Tohyama, M | 1 |
| Bellon, H; De Vleeschauwer, S; Heigl, T; Jungraithmayr, W; Somers, J; Van Raemdonck, DE; Vanaudenaerde, BM; Vandermeulen, E; Vaneylen, A; Verbeken, EK; Verleden, GM; Verleden, SE; Vos, R; Yamada, Y | 1 |
| Baumgartner, R; Behr, J; Brand, P; Herpich, C; Keller, M; Leuchte, H; Menges, G; Neurohr, C; Seitz, J; Sommerer, K; Tillmanns, S; Zimmermann, G | 1 |
| Arrigain, S; Aurora, P; Ballmann, M; Boyer, D; Conrad, C; Danziger-Isakov, LA; Eichler, I; Elidemir, O; Faro, A; Goldfarb, S; Mallory, GB; Michaels, MG; Mogayzel, PJ; Parakininkas, D; Solomon, M; Sweet, S; Visner, G; Worley, S | 1 |
| Arni, S; Hillinger, S; Inci, I; Jungraithmayr, W; Korom, S; Vogt, P; Weder, W | 1 |
| Krebs, R; Lemström, KB; Nykänen, A; Ropponen, JO; Syrjälä, SO; Tikkanen, JM | 1 |
| Bhorade, SM; Floreth, T; Garrity, ER; Stern, E; Stern, R; Tu, Y; White, SR | 1 |
| Anraku, M; Guan, Z; Hirayama, S; Hwang, DM; Keshavjee, S; Liu, M; Sato, M; Waddell, TK; Wagnetz, D; Yeung, JC | 1 |
| Aboyoun, C; Aubert, JD; Bravo, C; Glanville, AR; Klepetko, W; Knoop, C; Lama, R; Reichenspurner, H; Treede, H; Vettorazzi, E | 1 |
| Jeltsch, M; Jokinen, JJ; Krebs, R; Lemström, KB; Nykänen, AI; Ropponen, JO; Tikkanen, JM; Ylä-Herttuala, S | 1 |
| Charbonnier, LM; Estenne, M; Field, KA; Goldman, M; Iwakura, Y; Le Moine, A; Lemaître, PH; Leo, O; Remmelink, M; Vokaer, B | 1 |
| Fieguth, HG; Krueger, S; Otterbach, I; Wagner, TO; Wiedenmann, DE | 1 |
| Banner, NR; Cairn, J; Hodson, ME; Khaghani, A; Yacoub, M; Yek, T | 1 |
| Hasegawa, M; Nakagawa, K; Nakashima, Y; Okano, S; Shoji, F; Sueishi, K; Sugimachi, K; Yonemitsu, Y; Yoshino, I | 1 |
| Dupont, LJ; Van Raemdonck, D; Vanhaecke, J; Verleden, GM | 1 |
| Azzola, A; Black, J; Chhajed, P; Glanville, A; Havryk, A; Hostettler, K; Johnson, P; Roth, M; Tamm, M | 1 |
| Cerno, M; Damiani, D; Fanin, R; Fili', C; Geromin, A; Patriarca, F; Prosdocimo, S; Skert, C; Sperotto, A; Stocchi, R; Zaja, F | 1 |
| Aubert, JD; Auterith, A; Böttcher, H; Chaparro, C; Corris, P; Estenne, M; Gerbase, MW; Glanville, A; Klepetko, W; Knoop, C; Levvey, B; Niedermayer, J; Reichenspurner, H; Sarahrudi, K; Venuta, F; Verleden, G | 1 |
| Corcoran, TE; Dauber, JH; Grgurich, WF; Griffith, BP; Iacono, AT; Johnson, BA; McCurry, KR; Smaldone, GC; Smith, DA; Zeevi, A | 1 |
| Iacono, AT; Smith-Seiler, DA | 1 |
| Alho, HS; Maasilta, PK; Päiväniemi, OE; Salminen, US; Wolff, CH | 1 |
| Aris, R; Glanville, AR; Hmissi, A; Loyd, JE; McGiffin, DC; Pirron, U; Roman, A; Snell, GI; Sole, A; Valentine, VG; Vitulo, P | 1 |
| Dosanjh, A | 1 |
| Dupont, LJ; Verleden, GM | 1 |
| Aboyoun, CL; Glanville, AR; Malouf, MA; Morton, JM; Plit, M | 1 |
| Arbustini, E; Bini, F; Fietta, AM; Meloni, F; Morosini, M; Pellegrini, C; Solari, N; Vitulo, P | 1 |
| Ardehali, A; Belperio, JA; Burdick, MD; Gomperts, BN; Grusby, MJ; Hogaboam, C; Keane, MP; Kunkel, SL; Lukacs, NW; Lynch, JP; Nakamura, H; Ross, DJ; Saggar, R; Strieter, RM; Weigt, S; Xue, YY; Zisman, DA | 1 |
| Kinjo, S; Nagasaki, A; Nakachi, S; Takasu, N; Yamanoha, A | 1 |
| Ping, YM; Qi, Z; Wang, R; Wang, SZ; Yang, DY | 1 |
| Borro, JM; Bravo, C; Cifrián, JM; De la Torre, M; Lama, R; Laporta, R; Pastor, A; Román, A; Santos, F; Solé, A; Usetti, P; Zurbano, F | 1 |
| Aloush, AA; Chakinala, MM; Hachem, RR; Lynch, JP; Meyers, BF; Patterson, GA; Trulock, EP; Yusen, RD | 1 |
| Boehler, A; Rechsteiner, T; Remund, K; Rentsch, K; Russi, EW; Vogt, P | 1 |
| Bolman, RM | 1 |
| Griffith, BP; Hardesty, RL; Iacono, AT; Kawai, A; Keenan, RJ; Konishi, H; Nunley, DR; Paradis, IL; Weyant, RJ | 1 |
| Berry, GJ; Billingham, ME; Gregory, CR; Huang, X; Morris, RE; Rowan, R; Shorthouse, R | 1 |
| Bruggeman, CA; Duijvestijn, AM; Steinhoff, G; van Breda Vriesman, PJ; Yagyu, K | 1 |
| Burckart, GJ; Dauber, JH; Delgado, E; Duncan, SR; Grgurich, WF; Griffith, BP; Iacono, AT; Keenan, RJ; O'Riordan, TG; Ohori, NP; Paradis, IL; Smaldone, GC; Yousem, SA; Zeevi, A; Zendarsky, MM | 1 |
| Adams, B; Berry, GJ; Brazelton, T; Morris, RE; Reichenspurner, H; Reitz, BA; Shorthouse, R; Soni, V | 1 |
| Jordan, SC; Kass, RM; Koerner, SK; Nathan, SD; Ross, DJ | 1 |
| Esmore, DS; Snell, GI; Williams, TJ | 1 |
| Cremer, PD; Forsyth, CJ; Iland, HJ; Torzillo, P; Young, GA | 1 |
| Kallio, EA; Koskinen, PK; Krebs, R; Lemström, KB | 1 |
| Hertz, MI; Jessurun, J; King, MB; Murray, JJ; Savik, SK | 1 |
| Orsida, B; Snell, GI; Walters, EH; Ward, C; Williams, TJ; Wilson, JW | 1 |
| Berry, GJ; Brazelton, TR; Huang, X; Morris, RE; Nitschke, M; Reichenspurner, H; Reitz, BA; Shorthouse, R; Soni, V | 1 |
| Harjula, AL; Ikonen, T; Morris, RE; Salminen, US; Taskinen, E; Uusitalo, M | 1 |
| Cremer, J; Franke, U; Harringer, W; Haverich, A; Korff, F; Krug, N; Strüber, M; Wahlers, T; Wiebe, K | 1 |
| Banner, N; Habib, S; Rose, M; Walker, S; Yacoub, M | 1 |
| Cunningham, AC; Dark, JH; Kirby, JA; Moy, JV; Talbot, D; Walmsley, MW; Zhang, JG | 1 |
| Harjula, AL; Ikonen, T; Korpela, A; Maasilta, P; Salminen, US; Taskinen, E; Uusitalo, M | 1 |
| Corris, PA; Dark, JH; Doig, S; Fisher, AJ; Gabbay, E; Small, T | 1 |
| Alho, H; Harjula, AL; Ikonen, T; Maasilta, P; Salminen, US; Taskinen, E | 1 |
| Bishop, P; el-Gamel, A; Hutchinson, IV; Yonan, NA | 1 |
| Aavik, E; Buchdunger, E; Kallio, EA; Koskinen, PK; Lemström, KB | 1 |
| Harjula, AL; Maasilta, PK; Salminen, US; Taskinen, EI | 1 |
| Harjula, A; Hietala, EM; Ikonen, T; Maasilta, P; Salminen, US; Taskinen, E | 1 |
| Fabel, H; Harringer, W; Haverich, A; Hoeper, MM; Hoffmeyer, F; Niedermeyer, J; Spiekerkötter, E | 1 |
| Gu, Y; Kai, M; Lu, L; Onoda, K; Shimamoto, A; Shimono, T; Shimpo, H; Shiraishi, T; Takao, M; Tanaka, K; Yada, I | 1 |
| Bonser, RS; Lewis, ME; Llewellyn-Jones, CG; Revell, MP; Wilson, IC | 1 |
| Birsan, T; Klepetko, W; Meiser, B; Reichenspurner, H; Reichert, B; Treede, H; Wisser, W; Zuckermann, A | 1 |
| Funk, RH; Kasper, M; Ploetze, K; Roth-Eichhorn, S; Schade, I; Schueler, S; Wunderlich, J | 1 |
| Cipriani, P; Margiotta, MC; Mosca, G; Pecoraro, C; Quattrucci, S; Trancassini, M; Venuta, F | 1 |
| Balzer, DT; Cooper, JD; de la Morena, M; Guthrie, TJ; Huddleston, CB; Lynch, JP; Mendeloff, EN; Meyers, BF; Pasque, MK; Patterson, GA; Shapiro, S; Sundt, TM; Sweet, SC; Trulock, EP | 1 |
| McNeil, K; Sharples, LD; Stewart, S; Wallwork, J | 1 |
| Carretta, A; Dobrovits, M; Klepetko, W; Miwai Marta, G; Neuhauser, P; Papp, A; Ploner, M; Sarahrudi, K; Senbaklavaci, O; Wisser, W | 1 |
3 review(s) available for cyclosporine and Bronchiolitis, Exudative
| Article | Year |
|---|---|
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
Topics: Adult; Bronchiolitis Obliterans; Cyclosporine; Diabetes Mellitus; Graft Rejection; Humans; Hypertension; Immune Tolerance; Immunosuppression Therapy; Immunosuppressive Agents; Lung Transplantation; Middle Aged; Randomized Controlled Trials as Topic; Tacrolimus | 2013 |
Obliterative bronchiolitis in the lung transplant recipient. A powerful foe.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Bronchiolitis Obliterans; Chemotherapy, Adjuvant; Cyclosporine; Graft Rejection; Humans; Lung Transplantation; Retreatment; Therapies, Investigational; Treatment Outcome | 2004 |
Risk factors for bronchiolitis obliterans: a systematic review of recent publications.
Topics: Bronchiolitis Obliterans; Cyclosporine; Cytomegalovirus Infections; Graft Rejection; HLA-D Antigens; Humans; Immunosuppressive Agents; Lung Transplantation; MEDLINE; Risk Factors; Survival Analysis; Tissue Donors | 2002 |
10 trial(s) available for cyclosporine and Bronchiolitis, Exudative
| Article | Year |
|---|---|
A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation.
Topics: Administration, Inhalation; Bronchiolitis Obliterans; Cyclosporine; Humans; Lung; Lung Transplantation | 2022 |
Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
Topics: Adult; Bronchiolitis Obliterans; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; International Cooperation; Lung Transplantation; Male; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Risk Factors; Survival Rate; Syndrome; Tacrolimus; Treatment Outcome | 2012 |
Tacrolimus for treatment of bronchiolitis obliterans syndrome after unilateral and bilateral lung transplantation.
Topics: Adult; Bronchiolitis Obliterans; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Reoperation; Tacrolimus; Time Factors | 2002 |
Effect of switching from cyclosporine to tacrolimus on exhaled nitric oxide and pulmonary function in patients with chronic rejection after lung transplantation.
Topics: Adult; Breath Tests; Bronchiolitis Obliterans; Chronic Disease; Cyclosporine; Female; Forced Expiratory Volume; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Nitric Oxide; Prospective Studies; Tacrolimus | 2003 |
Everolimus versus azathioprine in maintenance lung transplant recipients: an international, randomized, double-blind clinical trial.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Everolimus; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lung; Lung Transplantation; Male; Middle Aged; Sirolimus; Syndrome | 2006 |
A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation.
Topics: Adult; Azathioprine; Bronchiolitis Obliterans; Bronchitis; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Postoperative Care; Tacrolimus | 2007 |
Clinical trial of tacrolimus versus cyclosporine in lung transplantation.
Topics: Acute Disease; Adult; Bronchiolitis Obliterans; Cross-Over Studies; Cyclosporine; Female; Follow-Up Studies; Fungemia; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Lung Transplantation; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Risk Factors; Survival Rate; Tacrolimus | 1995 |
FK506 rescue therapy in lung transplantation.
Topics: Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart-Lung Transplantation; Humans; Lung Transplantation; Patient Selection; Prednisolone; Tacrolimus | 1998 |
Azathioprine withdrawal in stable lung and heart/lung recipients receiving cyclosporine-based immunosuppression.
Topics: Acute Disease; Adult; Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft Rejection; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Prospective Studies; Respiratory Function Tests; Safety | 2000 |
Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols.
Topics: Acute Disease; Adult; Aged; Bronchiolitis Obliterans; Chronic Disease; Creatinine; Cyclosporine; Drug Combinations; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Infections; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Survival Rate; Tacrolimus; Time Factors; Treatment Outcome | 2001 |
59 other study(ies) available for cyclosporine and Bronchiolitis, Exudative
| Article | Year |
|---|---|
The Effect of Immunosuppression on Airway Integrity.
Topics: Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Dexamethasone; Endothelial Cells; Epithelial Cells; Epithelial-Mesenchymal Transition; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Inflammation; Interleukin-8; Lung; Lung Transplantation; Microcirculation; Mycophenolic Acid; Permeability; Tacrolimus; Tight Junctions | 2017 |
Sustained-Release Tacrolimus Stabilizes Decline of Forced Expiratory Volume in 1 Second Through Decreasing Fluctuation of Its Trough Blood Level.
Topics: Adolescent; Adult; Bronchiolitis Obliterans; Calcineurin Inhibitors; Cyclosporine; Delayed-Action Preparations; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Respiratory Function Tests; Tacrolimus; Young Adult | 2018 |
Up-regulation of alternate co-stimulatory molecules on proinflammatory CD28null T cells in bronchiolitis obliterans syndrome.
Topics: Adult; Bronchiolitis Obliterans; Case-Control Studies; CD28 Antigens; CD40 Ligand; Costimulatory and Inhibitory T-Cell Receptors; CTLA-4 Antigen; Cyclosporine; Female; Granzymes; Humans; Immunosuppressive Agents; Interferon-gamma; Lung Transplantation; Lymphocyte Activation; Male; Middle Aged; Perforin; Postoperative Complications; Receptors, OX40; T-Lymphocyte Subsets; Tacrolimus; Tumor Necrosis Factor Receptor Superfamily, Member 9; Tumor Necrosis Factor-alpha; Up-Regulation | 2013 |
Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation.
Topics: Adult; Bronchiolitis Obliterans; Calcineurin Inhibitors; Cell Proliferation; Cells, Cultured; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Forced Expiratory Volume; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lung; Male; Methylprednisolone; Mycophenolic Acid; Myofibroblasts; Sirolimus; Tacrolimus | 2014 |
An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Azithromycin; Biopsy; Bronchiolitis Obliterans; Cyclosporine; Disease Management; Forced Expiratory Volume; Gastroesophageal Reflux; Graft Rejection; Humans; Immunosuppressive Agents; Lung; Lung Transplantation; Reoperation; Risk Factors; Tacrolimus; Tomography, X-Ray Computed | 2014 |
Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin.
Topics: Antineoplastic Agents; Bronchiolitis Obliterans; Cyclophosphamide; Cyclosporine; Fatal Outcome; Female; Glucocorticoids; Humans; Immunity, Cellular; Immunoglobulins, Intravenous; Immunologic Factors; Japan; Lymphoma, B-Cell; Middle Aged; Mucous Membrane; Paraneoplastic Syndromes; Pemphigus; Rituximab | 2016 |
The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.
Topics: Airway Obstruction; Animals; Bronchiolitis Obliterans; Chronic Disease; Cyclosporine; Disease Models, Animal; Graft Rejection; Humans; Interleukin-17; Lung Transplantation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Steroids; Transplant Recipients; Transplantation, Homologous | 2016 |
Lung deposition of a liposomal cyclosporine A inhalation solution in patients after lung transplantation.
Topics: Administration, Inhalation; Aerosols; Aged; Bronchiolitis Obliterans; Chemistry, Pharmaceutical; Cyclosporine; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Immunosuppressive Agents; Liposomes; Lung; Lung Transplantation; Male; Middle Aged; Nebulizers and Vaporizers; Particle Size; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Pentetate; Vital Capacity | 2009 |
The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation.
Topics: Acute Disease; Bronchiolitis Obliterans; Child; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Europe; Female; Graft Rejection; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Incidence; Lung Transplantation; Male; Multivariate Analysis; North America; Retrospective Studies; Survival Analysis; Survivors; Tacrolimus | 2009 |
A model of chronic lung allograft rejection in the rat.
Topics: Actins; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bronchiolitis Obliterans; CD3 Complex; Chemokine CCL5; Chronic Disease; Cyclosporine; Disease Models, Animal; Fluorescent Antibody Technique; Forkhead Transcription Factors; Graft Rejection; Immunosuppressive Agents; Lung Transplantation; Macrophages, Alveolar; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Sirolimus; T-Lymphocytes, Helper-Inducer; Transforming Growth Factor beta; Transplantation, Homologous | 2010 |
Innate and adaptive immune responses in obliterative airway disease in rat tracheal allografts.
Topics: Adaptive Immunity; Animals; Bronchiolitis Obliterans; Cyclosporine; Graft Rejection; Immunity, Innate; Immunosuppressive Agents; Male; Rats; Rats, Inbred Strains; Rats, Inbred WF; Th1 Cells; Th17 Cells; Trachea; Transplantation, Heterotopic; Transplantation, Homologous | 2011 |
Differentiated transplant derived airway epithelial cell cytokine secretion is not regulated by cyclosporine.
Topics: Adult; Bronchiolitis Obliterans; Cell Differentiation; Cells, Cultured; Cyclosporine; Cytokines; Epithelial Cells; Epithelial-Mesenchymal Transition; Gene Expression Regulation; Humans; Immunosuppressive Agents; Inflammation Mediators; Intercellular Signaling Peptides and Proteins; Lung Transplantation; Middle Aged; Respiratory Mucosa; Transforming Growth Factor beta1 | 2011 |
Regression of allograft airway fibrosis: the role of MMP-dependent tissue remodeling in obliterative bronchiolitis after lung transplantation.
Topics: Adult; Airway Remodeling; Animals; Bronchiolitis Obliterans; Cyclosporine; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fibrosis; Humans; Immunosuppressive Agents; Lung; Lung Transplantation; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Myofibroblasts; Postoperative Complications; Rats; Transplantation, Homologous | 2011 |
Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis.
Topics: Adaptive Immunity; Animals; Bronchiolitis Obliterans; Chemotaxis; Cyclosporine; Dendritic Cells; Dose-Response Relationship, Drug; Down-Regulation; Epithelial Cells; Epithelium; Graft Rejection; Immunity, Innate; Immunoglobulins; Inflammation; Lymphangiogenesis; Macrophages; Neutrophils; Rats; Signal Transduction; Th17 Cells; Trachea; Transplantation, Homologous; Up-Regulation; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-3 | 2012 |
Cyclosporine A drives a Th17- and Th2-mediated posttransplant obliterative airway disease.
Topics: Animals; Blotting, Western; Bronchiolitis Obliterans; Cyclosporine; Cytokines; Flow Cytometry; Graft Rejection; Immunoenzyme Techniques; Immunosuppressive Agents; Interferon-gamma; Interleukin-17; Interleukin-4; Lung Transplantation; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Th2 Cells; Trachea; Transplantation, Heterotopic; Transplantation, Homologous | 2013 |
Time-related changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndrome.
Topics: Bronchiolitis Obliterans; Cyclosporine; Forced Expiratory Volume; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung; Lung Transplantation; Spirometry; Tacrolimus; Time Factors | 2003 |
Airway-directed gene transfer of interleukin-10 using recombinant Sendai virus effectively prevents post-transplant fibrous airway obliteration in mice.
Topics: Animals; Bronchiolitis Obliterans; Cyclosporine; Genetic Therapy; Genetic Vectors; Immunosuppressive Agents; Interleukin-10; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Models, Animal; Postoperative Complications; Respiratory Mucosa; Sendai virus; Trachea; Transplantation, Homologous; Transplantation, Isogeneic | 2003 |
Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.
Topics: Adult; Aged; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cell Division; Cells, Cultured; Cyclosporine; Everolimus; Female; Fibroblasts; Humans; Immunosuppressive Agents; Infections; Lung Diseases; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Sirolimus; Tacrolimus | 2004 |
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation.
Topics: Adolescent; Adult; Bronchiolitis Obliterans; Case-Control Studies; Cryptogenic Organizing Pneumonia; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Lung Diseases, Interstitial; Male; Middle Aged; Prednisone; Respiratory Function Tests; Retrospective Studies; Risk Factors; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 2004 |
International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
Topics: Acute Disease; Adult; Australia; Azathioprine; Bronchiolitis Obliterans; Canada; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; Forced Expiratory Volume; Graft Rejection; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Incidence; Kidney; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Retrospective Studies; Tacrolimus; Time Factors; Treatment Outcome | 2004 |
Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans.
Topics: Administration, Inhalation; Adult; Aerosols; Bronchiolitis Obliterans; Case-Control Studies; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Postoperative Complications; Proportional Hazards Models; Survival Analysis | 2004 |
Cyclooxygenase-2 expression in experimental post-transplant obliterative bronchiolitis.
Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Chondrocytes; Cyclooxygenase 2; Cyclosporine; Disease Models, Animal; Epithelial Cells; Everolimus; Fibroblasts; Fibrosis; Immunohistochemistry; Immunosuppressive Agents; Isoenzymes; Macrophages; Methylprednisolone; Postoperative Period; Prostaglandin-Endoperoxide Synthases; Sirolimus; Swine | 2004 |
Pirfenidone and chronic progressive obliterative airway disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchiolitis Obliterans; Cyclosporine; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Immunosuppressive Agents; Mice; Proteins; Pyridones; Rats | 2006 |
Inhaled cyclosporine in lung transplantation.
Topics: Administration, Inhalation; Bronchiolitis Obliterans; Cyclosporine; Immunosuppressive Agents; Lung Transplantation; Prevalence | 2006 |
Cyclosporine C2 target levels and acute cellular rejection after lung transplantation.
Topics: Acute Disease; Adolescent; Adult; Bronchiolitis Obliterans; Cyclosporine; Female; Graft Rejection; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged | 2006 |
Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors.
Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Azathioprine; Bronchiolitis Obliterans; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Female; Forkhead Transcription Factors; Gene Expression; Graft Rejection; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2 Receptor alpha Subunit; Lectins, C-Type; Lung Transplantation; Lymphocyte Activation; Lymphocyte Subsets; Male; Middle Aged; Mycophenolic Acid; Steroids; T-Lymphocytes, Regulatory; Tacrolimus | 2006 |
IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome.
Topics: Animals; Antibodies; Bronchiolitis Obliterans; Bronchoalveolar Lavage Fluid; Cyclosporine; Female; Fibrosis; Graft Rejection; Humans; Interleukin-13; Interleukin-4; Lung Transplantation; Male; Mice; Mice, Mutant Strains; Receptors, Interleukin-13; Syndrome; Transforming Growth Factor beta; Up-Regulation | 2007 |
Air-leak syndrome associated with bronchiolitis obliterans after allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Bronchiolitis Obliterans; Cyclosporine; Cytomegalovirus Infections; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Mediastinal Emphysema; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Radiography; Syndrome | 2007 |
[Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
Topics: Abdominal Cavity; Animals; Bronchiolitis Obliterans; Cyclosporine; Disease Models, Animal; Gene Expression; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Interleukin-2; Interleukin-4; Lung Transplantation; Postoperative Complications; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Trachea; Transplantation, Homologous | 2007 |
Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome.
Topics: Adult; Bronchiolitis Obliterans; Cyclosporine; Female; Forced Expiratory Volume; Humans; Immunosuppressive Agents; Lung Diseases; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Respiratory Function Tests; Retrospective Studies; Tacrolimus; Tissue Donors | 2007 |
Attenuation of airway obliteration by ciprofloxacin in experimental posttransplant bronchiolitis obliterans.
Topics: Animals; Bronchiolitis Obliterans; Ciprofloxacin; Cyclosporine; Immunosuppressive Agents; Male; Postoperative Complications; Rats; Rats, Inbred BN; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA; Trachea; Transplantation, Heterotopic; Transplantation, Homologous | 2008 |
Advantage--FK 506: reduced chronic rejection for lung transplant recipients.
Topics: Bronchiolitis Obliterans; Chronic Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Lung Transplantation; Randomized Controlled Trials as Topic; Tacrolimus | 1995 |
Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.
Topics: Animals; Bronchiolitis Obliterans; Cyclosporine; Graft Occlusion, Vascular; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Polyenes; Rats; Rats, Inbred BN; Rats, Inbred Lew; Sirolimus; Tunica Intima | 1995 |
Reactivation of cytomegalovirus with acute rejection and cytomegalovirus infection with obliterative bronchiolitis in rat lung allografts.
Topics: Animals; Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Cytomegalovirus Infections; Graft Rejection; Lung Transplantation; Prednisone; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous | 1993 |
Aerosolized cyclosporine in lung recipients with refractory chronic rejection.
Topics: Adult; Aerosols; Bronchiolitis Obliterans; Chronic Disease; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Respiratory Function Tests | 1996 |
Obliterative airway disease after heterotopic tracheal xenotransplantation in a concordant rodent model: pathogenesis and treatment.
Topics: Airway Obstruction; Animals; Bronchiolitis Obliterans; Cricetinae; Cyclosporine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mesocricetus; Polyenes; Rats; Rats, Inbred Lew; Sirolimus; Trachea; Transplantation, Heterologous | 1996 |
Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation. A plea for multicenter immunosuppressive trials.
Topics: Acute Disease; Antilymphocyte Serum; Azathioprine; Biopsy; Bronchiolitis Obliterans; Bronchoscopy; Chronic Disease; Clinical Trials as Topic; Cohort Studies; Confidence Intervals; Cyclosporine; Cytomegalovirus Infections; Graft Rejection; HLA Antigens; Humans; Immunosuppressive Agents; Lung Transplantation; Multicenter Studies as Topic; Muromonab-CD3; Pneumonia, Viral; Prednisone; Proportional Hazards Models; Retrospective Studies; Spirometry; Syndrome; Time Factors; Transplantation, Homologous | 1996 |
Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation.
Topics: Adult; Anti-Inflammatory Agents; Antibiotic Prophylaxis; Antilymphocyte Serum; Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Immunosuppressive Agents; Lung Transplantation; Lymphocyte Count; Male; Methylprednisolone; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Survivors; Syndrome; T-Lymphocytes, Helper-Inducer; Time Factors | 1996 |
Thalidomide responsive chronic pulmonary GVHD.
Topics: Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Bronchiolitis Obliterans; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Multiple Myeloma; Thalidomide | 1996 |
A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts.
Topics: Animals; Bronchiolitis Obliterans; Cyclosporine; Dose-Response Relationship, Drug; Epithelium; Guanidines; Histocompatibility Antigens Class II; Immunosuppressive Agents; Mycophenolic Acid; Postoperative Complications; Rats; Rats, Inbred Strains; Trachea; Transplantation Immunology; Transplantation, Homologous; Transplantation, Isogeneic | 1997 |
Cyclosporine reduces development of obliterative bronchiolitis in a murine heterotopic airway model.
Topics: Animals; Bronchiolitis Obliterans; Cyclosporine; Graft Rejection; Immunosuppressive Agents; Lung Transplantation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Trachea | 1997 |
Immunopathological changes in the airways of stable lung transplant recipients.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Biopsy; Bronchiolitis; Bronchiolitis Obliterans; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Lymphocyte Count; Lymphocyte Subsets; Male; Middle Aged; Postoperative Complications; Prednisolone; Time Factors | 1997 |
Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents.
Topics: Airway Obstruction; Animals; Bronchiolitis Obliterans; Cricetinae; Cyclosporine; Fluorescent Antibody Technique, Indirect; Immunosuppressive Agents; Male; Mesocricetus; Rats; Rats, Inbred BN; Rats, Inbred Lew; Trachea; Transplantation, Heterologous; Transplantation, Heterotopic; Transplantation, Homologous | 1997 |
Effect of immunosuppression on obliterative lesions in a heterotopic large-animal bronchial allograft model.
Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cartilage; Cyclosporine; Drug Therapy, Combination; Fibrosis; Immunosuppressive Agents; Inflammation; Methylprednisolone; Necrosis; Swine; Transplantation, Heterotopic; Transplantation, Homologous | 1997 |
Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis.
Topics: Biological Availability; Bronchiolitis Obliterans; Cyclosporine; Cystic Fibrosis; Follow-Up Studies; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors | 1998 |
Differential effects of cyclosporin A and tacrolimus on the production of TGF-beta: implications for the development of obliterative bronchiolitis after lung transplantation.
Topics: Bronchiolitis Obliterans; Cells, Cultured; Cyclosporine; Humans; Immunosuppressive Agents; Lung; Lung Transplantation; Tacrolimus; Transforming Growth Factor beta | 1998 |
Obliterative lesions in small airways in an immunosuppressed porcine heterotopic bronchial allograft model.
Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cyclosporine; Disease Models, Animal; Immunosuppression Therapy; Immunosuppressive Agents; Lung Transplantation; Methylprednisolone; Swine | 1998 |
Cross sectional study of exhaled nitric oxide levels following lung transplantation.
Topics: Breath Tests; Bronchiolitis Obliterans; Cross-Sectional Studies; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Nitric Oxide | 1998 |
Effects of rapamycin analogue SDZ RAD on obliterative lesions in a porcine heterotopic bronchial allograft model.
Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cartilage; Cyclosporine; Epithelium; Everolimus; Immunosuppressive Agents; Methylprednisolone; Mucous Membrane; Necrosis; Polyenes; Sirolimus; Swine; Transplantation, Heterotopic; Transplantation, Homologous | 1998 |
Tracheal allograft transplantation in rats: the role of immunosuppressive agents in development of obliterative airway disease.
Topics: Animals; Bronchiolitis Obliterans; Cyclosporine; Fibrosis; Graft Survival; Immunosuppressive Agents; Male; Mucous Membrane; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Regeneration; Tacrolimus; Trachea; Transplantation, Heterotopic; Transplantation, Homologous | 1998 |
Role of platelet-derived growth factor in obliterative bronchiolitis (chronic rejection) in the rat.
Topics: Animals; Bronchiolitis Obliterans; Cell Division; Chronic Disease; Cyclosporine; Enzyme Inhibitors; Graft Rejection; Immunohistochemistry; Immunosuppressive Agents; Male; Platelet-Derived Growth Factor; Polymerase Chain Reaction; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Respiratory Mucosa; Trachea; Transplantation, Homologous; Transplantation, Isogeneic | 1999 |
Obliterative lesions in a heterotopic bronchial xenograft model--a preliminary study.
Topics: Animals; Bronchi; Bronchiolitis Obliterans; Cartilage; Cyclosporine; Epithelium; Everolimus; Sheep; Sirolimus; Skin; Swine; Transplantation, Heterologous; Transplantation, Heterotopic | 2000 |
Obliterative airway disease in a porcine heterotopic bronchial allograft model.
Topics: Animals; Bronchi; Bronchiolitis Obliterans; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Respiratory Mucosa; Swine; Transplantation, Autologous; Transplantation, Homologous | 2000 |
The role of cyclosporine A and interleukin-2 in obliterative airway disease in a rat tracheal transplant model.
Topics: Animals; Bronchiolitis Obliterans; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Immunosuppressive Agents; Interleukin-2; Lung Transplantation; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; T-Lymphocytes; Trachea; Transplantation, Homologous | 2000 |
Conservation of small-airway function by tacrolimus/cyclosporine conversion in the management of bronchiolitis obliterans following lung transplantation.
Topics: Biopsy; Bronchi; Bronchiolitis Obliterans; Cyclosporine; Disease Progression; Follow-Up Studies; Forced Expiratory Volume; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Maximal Midexpiratory Flow Rate; Retrospective Studies; Spirometry; Statistics, Nonparametric; Syndrome; Tacrolimus | 2000 |
Anti-proliferative properties of the phosphodiesterase-4 inhibitor rolipram can supplement immunosuppressive effects of cyclosporine for treatment of obliterative bronchiolitis in heterotopic rat allografts.
Topics: Animals; Bronchiolitis Obliterans; Cyclosporine; Epithelial Cells; Immunosuppressive Agents; Male; Phosphodiesterase Inhibitors; Rats; Rats, Inbred BN; Rats, Inbred Lew; Rolipram; Trachea; Transplantation, Heterotopic; Transplantation, Homologous; Transplantation, Isogeneic | 2001 |
Microbiologic investigation on patients with cystic fibrosis subjected to bilateral lung transplantation.
Topics: Bronchiolitis Obliterans; Bronchoalveolar Lavage Fluid; Cyclosporine; Cystic Fibrosis; Follow-Up Studies; Gram-Negative Bacteria; Humans; Immunosuppressive Agents; Lung Transplantation; Oxygen Consumption; Sputum; Survival Rate; Tacrolimus | 2001 |
Lung transplantation for pulmonary vascular disease.
Topics: Adolescent; Adult; Bronchiolitis Obliterans; Child; Child, Preschool; Cyclosporine; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Infant; Lung Transplantation; Male; Middle Aged; Retrospective Studies; Survival Analysis | 2002 |
The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation.
Topics: Acute Disease; Adult; Bronchiolitis Obliterans; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Tacrolimus | 2002 |